Recruiting studies: Oral Pre Exposure Prophylaxis Prep

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)
Phase 3 · 30 location(s) · Merck Sharp & Dohme LLC · NCT07071623 A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Phase 3 · 81 location(s) · Merck Sharp & Dohme LLC · NCT07044297 PathToScale: The PERSIST Trial
NA · 1 location(s) · Georgetown University · NCT07221747 BetterInfo on Women's PrEP Choices and Outcomes in Malawi
NA · 1 location(s) · Johns Hopkins Bloomberg School of Public Health · NCT07579754 PrEPared to Choose (PtC) is an Implementation Study of the Delivery of Cabotegravir Long-acting, an Injectable Pre-expos
Phase N/A · 1 location(s) · Desmond Tutu HIV Foundation · NCT06807736

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.